Enhanced Group (ENHA) Q2 2026 earnings summary

Executive summary

• Completed business combination and began trading on NYSE in May 2026, transitioning from pre-revenue to public company and launching the inaugural Enhanced Games and Live Enhanced platform.

• Achieved $17.7 million in Q2 2026 revenue, primarily from sponsorships tied to the inaugural Enhanced Games, which reached over one billion people globally and set a world record.

• Net loss for Q2 2026 was $61.9 million, reflecting heavy investment in event infrastructure, clinical trials, and public company operations.

• Built a strong brand and community, securing $32 million in sponsorships and partnerships with major companies like Rezolve AI and Roku, and achieving significant media coverage.

• Launched Live Enhanced platform with 11 Rx therapies and 2 proprietary supplements, expanding into 34 countries.

Financial highlights

• Q2 2026 revenue was $17.7 million, compared to no revenue a year ago, almost entirely from sponsorships.

• Operating expenses for Q2 were $79.6 million, including $52 million in event costs, $16.6 million SG&A, and $10.9 million transaction expenses.

• Adjusted EBITDA loss for Q2 2026 was $42.7 million, with a net loss margin of (350%).

• Cash and cash equivalents were $19.6 million as of June 30, 2026, down from $25.3 million at year-end 2025.

• Cash used in operating activities was $44.0 million for the first six months of 2026.

Outlook and guidance

• Expects continued growth in telehealth and supplement platform, with new product categories and the Enhanced OS platform launching later in the year.

• Future events to be more capital-efficient, leveraging existing infrastructure and expanding participatory formats.

• Remaining sponsorship revenue from $32 million in contracts to be recognized in future periods as obligations are met.

• Management highlights substantial doubt about ability to continue as a going concern without additional capital.

• Focus on growing performance medicine business and evaluating strategic M&A and partnerships.